of high sensitivity cardiac troponins in patients with chronic kidney disease with and without acute myocardial infarction. Clin Biochem. 2015 Mar;48(4-5):247-53. \[[PubMed: 25617663](https://pubmed.ncbi.nlm.nih.gov/25617663)\] 73. Korff S, Katus HA, Giannitsis E. Differential diagnosis of elevated troponins. Heart. 2006 Jul;92(7):987-93. \[[PMC free article: PMC1860726](/pmc/articles/PMC1860726/)\] \[[PubMed: 16775113](https://pubmed.ncbi.nlm.nih.gov/16775113)\] 74. Han X, Zhang S, Chen Z, Adhikari BK, Zhang Y, Zhang J, Sun J, Wang Y. Cardiac biomarkers of heart failure in chronic kidney disease. Clin Chim Acta. 2020 Nov;510:298-310. \[[PubMed: 32710942](https://pubmed.ncbi.nlm.nih.gov/32710942)\] 75. Harley K, Bissonnette S, Inzitari R, Schulz K, Apple FS, Kavsak PA, Gunsolus IL. Independent and combined effects of biotin and hemolysis on high-sensitivity cardiac troponin assays. Clin Chem Lab Med. 2021 Jul 27;59(8):1431-1443. \[[PubMed: 33761581](https://pubmed.ncbi.nlm.nih.gov/33761581)\] 76. Januzzi JL, Hahn SS, Chae CU, Giugliano R, Lewandrowski K, Theroux P, Jang IK. Effects of tirofiban plus heparin versus heparin alone on troponin I levels in patients with acute coronary syndromes. Am J Cardiol. 2000 Oct 01;86(7):713-7. \[[PubMed: 11018188](https://pubmed.ncbi.nlm.nih.gov/11018188)\] 77. Sanders A, Gama R, Ashby H, Mohammed P. Biotin immunoassay interference: A UK-based prevalence study. Ann Clin Biochem. 2021 Jan;58(1):66-69. \[[PubMed: 32936669](https://pubmed.ncbi.nlm.nih.gov/32936669)\] 78. Dasgupta A. Immunoassay design and biotin interference. Adv Clin Chem. 2022;109:165-183. \[[PubMed: 35953126](https://pubmed.ncbi.nlm.nih.gov/35953126)\] 79. Ismail AA, Walker PL, Cawood ML, Barth JH. Interference in immunoassay is an underestimated problem. Ann Clin Biochem. 2002 Jul;39(Pt 4):366-73. \[[PubMed: 12117440](https://pubmed.ncbi.nlm.nih.gov/12117440)\] 80. Sanmartin N, Garcia C, Bugier S, Malfuson JV, Chianea D, Renard C, Vest P. [Heterophilic antibodies: be carefull!]. Ann Biol Clin (Paris). 2013 Jul-Aug;71(4):475-80. \[[PubMed: 23906579](https://pubmed.ncbi.nlm.nih.gov/23906579)\] 81. Zhu Y, Jenkins MM, Brass DA, Ravago PG, Horne BD, Dean SB, Drayton N. Heterophilic antibody interference in an ultra-sensitive 3-site sandwich troponin I immunoassay. Clin Chim Acta. 2008 Sep;395(1-2):181-2. \[[PubMed: 18503763](https://pubmed.ncbi.nlm.nih.gov/18503763)\] 82. Lippi G, Aloe R, Meschi T, Borghi L, Cervellin G. Interference from heterophilic antibodies in troponin testing. Case report and systematic review of the literature. Clin Chim Acta. 2013 Nov 15;426:79-84. \[[PubMed: 24041812](https://pubmed.ncbi.nlm.nih.gov/24041812)\] 83. Cassin M, Cappelletti P, Rubin D, Zaninotto M, Macor F, Nicolosi GL. [Two cases of false troponin I increase in patients with heterophile antibodies]. Ital Heart J Suppl. 2002 Feb;3(2):235-8. \[[PubMed: 11926033](https://pubmed.ncbi.nlm.nih.gov/11926033)\] 84. Kricka LJ. Human anti-animal antibody interferences in immunological assays. Clin Chem. 1999 Jul;45(7):942-56. \[[PubMed: 10388468](https://pubmed.ncbi.nlm.nih.gov/10388468)\] 85. Kricka LJ, Schmerfeld-Pruss D, Senior M, Goodman DB, Kaladas P. Interference by human anti-mouse antibody in two-site immunoassays. Clin Chem. 1990 Jun;36(6):892-4. \[[PubMed: 2192822](https://pubmed.ncbi.nlm.nih.gov/2192822)\] 86. Bolstad N, Warren DJ, Nustad K. Heterophilic antibody interference in immunometric assays. Best Pract Res